PAVmed (PAVM) Non-Current Debt (2017 - 2020)

PAVmed (PAVM) recorded quarterly Non-Current Debt of $100000.0 in Q3 2020, down 33.33% quarter-over-quarter from $150000.0 in Q2 2020.

PAVmed (PAVM) Non-Current Debt (2017 - 2020) Analysis & Trends

PAVmed's Non-Current Debt history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2020.

In Q3 2020, Non-Current Debt changed N/A year-over-year to $100000.0; the TTM figure through Sep 2020 stood at $100000.0 (changed N/A YoY), while the FY2019 annual figure was $8.1 million, changed N/A from the prior year.
Non-Current Debt was $100000.0 for Q3 2020 at PAVmed, down from $150000.0 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $8.1 million in Q4 2019 to a low of $20663.0 in Q1 2020.
Historically, Non-Current Debt has averaged $2.0 million across 4 years, with a median of $1.6 million in 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	29.64 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	14.22 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	598.50 Mn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	10.13 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	1.81 Bn
10	PAVmed	3.32 Mn	-9.85 Mn	-703,000.00	-

Download Data